SCM
PRCT icon

Soleus Capital Management’s Procept Biorobotics PRCT Stock Holding History

Soleus Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4M Buy
+160,000
New +$4.51M 0.16% 69
2021
Q4 		– Sell
-20,000
Closed -$763K – 84
2021
Q3 		$763K Buy
+20,000
New +$768K 0.12% 67

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Soleus Capital Management's PRCT Position: Q1 2026 in Review

Soleus Capital Management opened a new position in Procept Biorobotics (PRCT) in Q1 2026: 160,000 shares worth $4M. The stake represents 0.16% of the portfolio and ranks #69 among its holdings. This is a return to the name: Soleus Capital Management previously reported a position in PRCT as recently as Q3 2021.

Soleus Capital Management first reported a position in PRCT in Q3 2021 and has held it in 2 quarters since. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Soleus Capital Management held 160,000 shares of Procept Biorobotics worth $4M as of Q1 2026.
  • Procept Biorobotics was a new Soleus Capital Management position in Q1 2026.
  • Procept Biorobotics made up 0.16% of Soleus Capital Management's portfolio in Q1 2026, its #69 holding.
  • Soleus Capital Management first reported a position in Procept Biorobotics in Q3 2021 and has held it in 2 quarters since.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.